Most people researching stem cell therapy spend hours reading about the science, comparing treatment protocols, and scrolling through patient testimonials. Very few think to ask about the lab. That’s a problem, because the lab is where everything that actually matters happens. At Stem Cells Colombia, we field a lot of questions from prospective patients, and the ones who ask about our laboratory certification are the ones who understand what they’re really evaluating. For everyone else, this article is meant to fill that gap.
Colombia has become a genuine destination for patients seeking stem cell therapy. The country has trained physicians, established medical infrastructure, and a regulatory framework that, when followed, can produce treatment standards that hold up to international scrutiny. But not every clinic follows that framework. Not every lab processing cells in Colombia is doing so under the conditions that protect patients from serious harm. Certification is the clearest, most objective way to tell the difference, and this article will walk you through exactly what to look for and why it matters more than anything else on a clinic’s website.

What Does GMP Actually Mean
GMP stands for Good Manufacturing Practices. It is a quality assurance framework originally developed for pharmaceutical manufacturing, and it has since become the international standard for any facility producing biologics, including cell therapy products. When a lab is GMP-certified, it means an independent regulatory authority has inspected that facility and confirmed it meets a defined set of requirements for how products are made, tested, documented, and released.
Several governing bodies issue and enforce GMP standards worldwide. The World Health Organization publishes GMP guidelines that serve as a baseline across many countries. The European Union applies GMP rules specifically to advanced therapy medicinal products through its regulatory framework. In the United States, the FDA enforces what it calls current Good Manufacturing Practices, or cGMP. In Colombia, the relevant authority is INVIMA, the Instituto Nacional de Vigilancia de Medicamentos y Alimentos, which oversees biologics and issues its own BPM certification, or Buenas Prácticas de Manufactura.
GMP certification addresses several core areas of lab operations. These include the physical design of the facility, the classification and control of the air environment, the qualification of equipment, the sourcing and traceability of raw materials, the training of personnel, the documentation of every processing step, and the quality control testing that every product batch must pass before it reaches a patient. Each of these areas exists to prevent a specific category of failure. Together, they form a system designed to make sure that what goes into a patient’s body is exactly what it’s supposed to be, nothing more and nothing less.

Why GMP Certification Is Especially Critical for Stem Cell Therapy
Stem cells are not pills. They are not chemicals synthesized in a controlled reaction. They are living biological products, and that distinction changes the nature of the risk entirely.
A contaminated tablet might cause a localized problem. A contaminated cell preparation administered intravenously or directly into a joint can cause systemic infection, septic shock, or death. The biological risks specific to stem cell preparations are serious and, in a non-certified environment, very real.
Bacterial and fungal contamination can turn a treatment into a life-threatening infection. Cross-contamination between donor samples can compromise both identity and safety. Cell viability is a separate concern: cells that have been improperly stored or processed may arrive at the administration site with a viability rate too low to produce any therapeutic effect, and dead or damaged cells can trigger inflammatory responses in the body. Mycoplasma is a particularly insidious threat because it is invisible to standard observation and requires specific testing to detect. Endotoxins, which are fragments of bacterial cell walls that survive even after sterilization, can cause fever and sepsis in patients even when the preparation appears sterile by basic standards.
None of these risks can be assessed by reading a clinic’s marketing copy. Phrases like “sterile lab” and “quality cells” are not regulated claims. They mean nothing without documentation. A GMP-certified facility has demonstrated through formal inspection that its environment, processes, and testing protocols actually control for these risks. An uncertified facility has not made that demonstration, regardless of how it describes itself online.

Colombia’s Regulatory Framework for Cell Therapy Labs
INVIMA functions as Colombia’s equivalent of the FDA. It is the agency responsible for regulating pharmaceuticals, biologics, medical devices, and food safety across the country. For cell therapy products, INVIMA classifies stem cell preparations as biological medicines, which means facilities that manufacture them are subject to BPM requirements, Colombia’s national GMP standard.
It is worth understanding the difference between the clinic that administers a therapy and the lab that manufactures the cell product. These may be the same organization or different ones, but both are subject to regulation. A clinic can have excellent physicians and still be sourcing cells from a lab that has no formal certification. Patients need to ask about both.
A legitimate Colombian cell therapy lab should be able to show several things. First, it should hold a INVIMA manufacturing authorization for biological products. Second, it should have BPM certification for its cell processing operations. Additional ISO certifications, such as ISO 9001 for quality management or ISO 13485 for medical device quality systems, indicate that the facility is operating under internationally recognized standards beyond the minimum national requirement.
Colombia’s regulatory system is functional and capable of enforcing these standards, but enforcement is not uniform across all providers. The responsibility ultimately falls on patients to verify that the clinic they choose is compliant, not just compliant-sounding.

What a GMP Certified Lab Actually Looks Like
A certified cell therapy lab looks different from a standard clinical or research laboratory, and the differences are not cosmetic.
The processing environment is built around ISO-classified cleanrooms. Final cell processing typically requires an ISO 5 environment, also called a Class 100 cleanroom, which means the air contains no more than 100 particles of 0.5 microns or larger per cubic foot. Maintaining that level of air cleanliness requires HEPA filtration systems, pressure differentials between rooms to prevent contaminated air from moving in the wrong direction, and continuous environmental monitoring through particle counters and air sampling cultures.
The equipment inside a GMP lab is not just functional, it is validated. Biosafety cabinets are certified to Class II standards or higher. Incubators are equipped with continuous temperature and CO2 monitoring with alarm systems. Cryogenic storage tanks are validated for the temperature ranges required to maintain cell viability over time. Centrifuges, microscopes, and cell counters are calibrated on regular schedules, and those calibration records are maintained and available for audit.
Documentation in a GMP lab is not optional. Every batch of cells processed is assigned a unique lot number that follows the product from donor sourcing through processing to patient administration. Batch records document every step taken, every reading observed, and every person involved. If something goes wrong, the deviation is documented and a corrective action process is initiated. This level of traceability protects patients and allows problems to be identified and addressed rather than ignored.
Before any cell preparation is released for patient use, it must pass a battery of quality control tests. These include sterility testing to confirm the absence of bacterial and fungal contamination, mycoplasma testing, endotoxin testing using a limulus amebocyte lysate assay, cell viability testing with most labs requiring a minimum of 70 to 80 percent viable cells for release, cell identity confirmation through flow cytometry to verify surface markers, and potency assays where applicable. A product that fails any of these tests should not be released, and in a properly run GMP lab, it will not be.

Red Flags That a Lab Is Not GMP Compliant
Knowing what a certified lab looks like makes it easier to recognize what one doesn’t look like.
A lab that cannot produce documentation is a lab that cannot prove it meets any standard at all. If a clinic refuses to share its INVIMA authorization or cannot describe its cleanroom classification, that is a serious warning sign. The same applies to pricing: running a certified lab with proper QC testing is expensive. A clinic offering stem cell therapy at prices that seem too good to be true is almost certainly cutting corners somewhere, and the lab is the most likely place those corners are being cut.
Other red flags include cells that are processed on-site in a facility that was not purpose-built for that function, staff without formal training in aseptic technique or cell biology, and no clear protocol for what happens if a batch fails testing. Offshore cells shipped without validated cold chain documentation are another concern. Temperature excursions during shipping can kill cells or compromise their viability without any visible sign that something went wrong.

Questions to Ask Any Stem Cell Clinic Before You Commit
Patients have every right to ask detailed questions before proceeding with treatment, and a reputable clinic will welcome them. Here is a working list.
Is your cell processing lab GMP-certified, and under which authority? Can you provide your INVIMA manufacturing authorization? What is the cleanroom classification of your processing environment? What quality control tests does every cell batch undergo before administration, and what are the minimum release criteria? How is donor material screened and what documentation is available? Who is the scientific director overseeing lab operations, and what are their qualifications? What happens if a batch fails QC testing? Can I receive a certificate of analysis for my specific cell preparation?
If a clinic cannot answer these questions, or answers them evasively, that is information worth taking seriously.

Why Certification Matters More Than Testimonials or Photos
A patient who received treatment at a non-certified lab and reported a good outcome was not proof that the lab was safe. They were proof that they were fortunate. The risks created by a non-GMP environment are probabilistic, not certain. Most contaminated products don’t cause visible harm. Some do. The patients who are harmed rarely end up in the marketing materials of the clinics responsible.
Social proof is valuable for many things. It is not a substitute for process verification when the stakes involve your health. A before-and-after photo tells you nothing about what was in the syringe. A testimonial tells you nothing about what tests were run on the cells before they were administered. Certification tells you that an independent authority reviewed the facility’s operations and found them to meet a defined standard. That is an entirely different category of evidence.
The asymmetry here is worth stating clearly. If you choose a certified lab and the treatment doesn’t produce the outcome you hoped for, that is a medical outcome question. If you choose an uncertified lab and something goes wrong with the product itself, the consequences can be catastrophic and irreversible. The downside is not equivalent.
Conclusion
When you are evaluating stem cell therapy in Colombia, laboratory certification is not a bureaucratic detail buried in the fine print. It is the single most important safety check available to you as a patient, because it is the only externally verified proof that the cells being prepared for your treatment were processed under conditions designed to protect you.
Colombia has the scientific talent, the medical infrastructure, and the regulatory framework to deliver cell therapy that meets international standards. The question is not whether that standard exists. The question is whether the clinic you are considering is actually operating within it.
If you want to ask any of the questions listed in this article, contact us directly. We will answer them.